Single-Cell Omics Market Comprehensive Study: Forecasted Market Size And Growth Rate

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Single-Cell Omics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The single-cell omics market size has grown rapidly in recent years. It will grow from $1.81 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to cellular heterogeneity discovery, emergence of single-cell analysis tools, biomedical research progress, immune system characterization, rise of precision medicine.

The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to clinical adoption and diagnostics, integration with multi-omics approaches, application in regenerative medicine, drug development and discovery, cellular therapies and immunotherapies. Major trends in the forecast period include in vivo single-cell studies, single-cell omics in infectious disease research, microfluidics and single-cell sorting, single-cell multi-omics integration, spatial single-cell profiling.

Get Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Market Segmentation:
The single-cell omics market covered in this report is segmented -

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing
3) By Application: Oncology, Cell Biology, Neurology, Immunology
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Major Driver - Rising Cancer Prevalence Propels Growth In The Single-Cell Omics Market
The rising prevalence of cancer is expected to propel the growth of the single-cell omics market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Identifying biomarkers for cancer diagnosis, prognosis prediction and discovering novel therapeutic targets in predetermined clinical cohorts has made substantial use of single-cell omics data. For instance, in 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1.9 million new cancer cases are expected to be diagnosed in the US in 2021, an increase compared to more than 1.8 million new cancer cases diagnosed in 2020. Therefore, the rising prevalence of cancer is driving the growth of the single-cell omics market.

Competitive Landscape:
Major companies operating in the single-cell omics market report are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Top Trend - Product Innovation Marks A Milestone In Single-Cell Omics Market
Product innovation is a key trend gaining popularity in the single-cell omics market. Major companies operating in the single-cell omics market are developing innovative products to sustain their position in the market. For instance, in May 2023, Deepcell, a US-based software provider for single-cell dimensional morphology analysis, launched REM-I Platform, a scalable single-cell imaging, high-dimensional analysis, and cell sorting that provide previously unattainable insights into cell biology. The REM-I Platform will stimulate new ways of discovery in various domains, including cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening, among others, by combining single-cell imaging, sorting, and high-dimensional analysis.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Single-Cell Omics Market Characteristics
3. Single-Cell Omics Market Trends And Strategies
4. Single-Cell Omics Market - Macro Economic Scenario
5. Single-Cell Omics Market Size And Growth
…..
27. Single-Cell Omics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

This release was published on openPR.